The histone KMT SETDB1, a key stemness factor both in embryonic and adult stem cells [11, 12], has emerged as a predominant oncogene in a wide range of solid cancers and hematological malignancies [13–15] promoting chemoresistance [10]. This evidence concerns the gene SETDB1 and hematologic disorder.